148 related articles for article (PubMed ID: 31388257)
1. Hepatitis B and C Virus Reactivation Patterns in a Romanian Cohort of Patients with Chronic Lymphoproliferative Disorders.
Molagic V; Mihailescu R; Tiliscan C; Popescu C; Vladareanu AM; Catana R; Radulescu M; Arama V; Arama SS
Indian J Hematol Blood Transfus; 2019 Jul; 35(3):459-464. PubMed ID: 31388257
[TBL] [Abstract][Full Text] [Related]
2. The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.
Vladareanu AM; Ciufu C; Neagu AM; Onisai M; Bumbea H; Vintilescu AM; Dobrea C; Arama V; Mihailescu R; Arama S
J Med Life; 2010; 3(3):320-9. PubMed ID: 20945824
[TBL] [Abstract][Full Text] [Related]
3. Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses.
Ciufu C; Arama V; Bumbea H; Dobrea C; Ion I; Vladareanu AM
J Med Life; 2013; 6(4):464-71. PubMed ID: 24868264
[TBL] [Abstract][Full Text] [Related]
4. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
Preda CM; Popescu CP; Baicus C; Constantinescu I; Oproiu A; Voiosu T; Diculescu M; Negreanu L; Gheorghe L; Sporea I; Trifan A; Ceausu E; Proca D; Manuc M
J Viral Hepat; 2018 Jul; 25(7):834-841. PubMed ID: 29397016
[TBL] [Abstract][Full Text] [Related]
5. The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.
Bumbea H; Vladareanu AM; Vintilescu A; Radesi S; Ciufu C; Onisai M; Baluta C; Begu M; Dobrea C; Arama V; Streinu-Cercel A; Arama S
J Med Life; 2011 Aug; 4(3):256-63. PubMed ID: 22567048
[TBL] [Abstract][Full Text] [Related]
6. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature.
Snast I; Atzmony L; Braun M; Hodak E; Pavlovsky L
J Am Acad Dermatol; 2017 Jul; 77(1):88-97.e5. PubMed ID: 28495497
[TBL] [Abstract][Full Text] [Related]
7. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C.
Kawagishi N; Suda G; Onozawa M; Kimura M; Maehara O; Ohara M; Izumi T; Umemura M; Ito J; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N
J Viral Hepat; 2017 Dec; 24(12):1098-1106. PubMed ID: 28632923
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
Fujiwara K; Tanaka Y; Orito E; Ohno T; Kato T; Sugauchi F; Suzuki S; Hattori Y; Sakurai M; Hasegawa I; Ozasa T; Kanie F; Kano H; Ueda R; Mizokami M
J Gastroenterol Hepatol; 2004 Dec; 19(12):1343-7. PubMed ID: 15610306
[TBL] [Abstract][Full Text] [Related]
9. Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.
Yanny BT; Latt NL; Saab S; Han S; Choi G; Kramer J; Sahota AK
J Clin Gastroenterol; 2018; 52(10):908-912. PubMed ID: 29334502
[TBL] [Abstract][Full Text] [Related]
10. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
Bonifati C; Lora V; Graceffa D; Nosotti L
World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection.
Liu CH; Liu CJ; Su TH; Fang YJ; Yang HC; Chen PJ; Chen DS; Kao JH
Open Forum Infect Dis; 2017; 4(1):ofx028. PubMed ID: 28480296
[TBL] [Abstract][Full Text] [Related]
12. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
[TBL] [Abstract][Full Text] [Related]
13. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
Yang HC; Tsou HH; Pei SN; Chang CS; Chen JH; Yao M; Lin SJ; Lin J; Yuan Q; Xia N; Liu TW; Chen PJ; Cheng AL; Hsu C;
J Hepatol; 2018 Aug; 69(2):286-292. PubMed ID: 29551710
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.
Sagnelli C; Pisaturo M; Calò F; Martini S; Sagnelli E; Coppola N
World J Gastroenterol; 2019 Jul; 25(26):3299-3312. PubMed ID: 31341357
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.
Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lie AK; Lai CL; Kwong YL; Yuen MF
J Clin Oncol; 2014 Nov; 32(33):3736-43. PubMed ID: 25287829
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
Chakravarti A; Verma V; Jain M; Kar P
Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.
Shimozuma Y; Ito T; Inokuchi M; Uchikoshi M; Miyashita M; Nozawa H; Shimazaki T; Hiroishi K; Imawari M
J Med Virol; 2010 Dec; 82(12):2064-72. PubMed ID: 20981794
[TBL] [Abstract][Full Text] [Related]
19. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
[TBL] [Abstract][Full Text] [Related]
20. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.
Stroffolini T; Sagnelli E; Sagnelli C; Smedile A; Furlan C; Morisco F; Coppola N; Andriulli A; Almasio PL
Dig Liver Dis; 2019 Mar; 51(3):434-437. PubMed ID: 30361062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]